AGP Ltd
Shariah compliantAlphaGen's view
Members only- Alpha scoreHow this quarter's business compares, scored 0–100
- Fair valueWhat the stock may be worth, against today's price
- Trend signalWhether the price trend is up, down or stopping
- Sector rankWhere it stands among its sector peers
Latest results
Quarter: Apr–Jun 2026In the Apr–Jun 2026 quarter, AGP's sales fell 16% to Rs 4.7bn, from Rs 5.6bn, and profit after tax fell 8% to Rs 586.5mn, from Rs 636.0mn (compared with Apr–Jun 2025).
Earnings per share were Rs 2.15, against Rs 2.20 a year earlier. The company reported a dividend of Rs 2.00 per share for the quarter.
At Rs 150.06, AGP trades at 12.7 times earnings, with a dividend yield of 4.7%.
- P/E ratio
- 12.7
- Dividend yield
- 4.7%
- Dividend payout
- 93%
- of earnings
- Return on equity
- 25%
- Net margin
- 15.0%
- trailing twelve months
- Debt to equity
- 0.73
AGP quarterly results
Reported figures| Quarter | Sales | Profit after tax | Net margin | EPS | Dividend / share |
|---|---|---|---|---|---|
| Apr–Jun 2026 | Rs 4.7bn | Rs 586.5mn | 12.5% | Rs 2.15 | Rs 2.00 |
| Jan–Mar 2026 | Rs 6.8bn | Rs 968.0mn | 14.1% | Rs 3.06 | — |
| Oct–Dec 2025 | Rs 8.5bn | Rs 1.5bn | 17.2% | Rs 4.38 | Rs 6.00 |
| Jul–Sep 2025 | Rs 7.6bn | Rs 1.2bn | 15.4% | Rs 3.72 | — |
| Apr–Jun 2025 | Rs 5.6bn | Rs 636.0mn | 11.4% | Rs 2.20 | Rs 2.00 |
| Jan–Mar 2025 | Rs 7.2bn | Rs 1.1bn | 14.8% | Rs 3.04 | — |
| Oct–Dec 2024 | Rs 7.4bn | Rs 1.4bn | 18.6% | Rs 4.27 | Rs 4.00 |
| Jul–Sep 2024 | Rs 6.0bn | Rs 733.0mn | 12.2% | Rs 2.47 | — |
AGP annual results and dividends
Reported figures| Year | Sales | Profit after tax | EPS | Dividend / share |
|---|---|---|---|---|
| Year to Dec 2025 | Rs 28.9bn | Rs 4.3bn | Rs 13.34 | Rs 8.00 |
| Year to Dec 2024 | Rs 25.0bn | Rs 3.0bn | Rs 9.53 | Rs 4.00 |
| Year to Dec 2023 | Rs 18.7bn | Rs 1.8bn | Rs 5.59 | Rs 2.50 |
| Year to Dec 2022 | Rs 14.5bn | Rs 1.7bn | Rs 5.61 | Rs 2.00 |
| Year to Dec 2021 | Rs 9.3bn | Rs 1.8bn | Rs 6.24 | Rs 2.50 |
Balance sheet and price
Balance sheet as of Jun 2026- Total assets
- Rs 32.5bn
- Shareholders' equity
- Rs 16.7bn
- Cash & bank
- Rs 409.6mn
- Total debt
- Rs 12.3bn
- Current ratio
- 0.88
- 3-month high
- Rs 217.93
- 3-month low
- Rs 150.06
- 1-month change
- -8.4%
- 3-month change
- -30.3%
Read more about AGP
Other pharmaceuticals companies
- ABOTAbbot Laboratories (Pakistan) LtdRs 927.73P/E 11.1
- BFBIOBF Biosciences LtdRs 127.51P/E 20.0
- CPHLCiti Pharma LtdRs 71.86P/E 15.7
- FEROZFerozsons Laboratories LtdRs 325.07P/E 16.4
- GLAXOGlaxoSmithKline Pakistan LtdRs 316.42P/E 10.4
- HALEONHaleon Pakistan LtdRs 680.74P/E 12.7
- HINOONHighnoon Laboratories LtdRs 948.13P/E 12.1
- HPLHoehcst Pakistan LtdRs 3905.85P/E 10.4
- IBLHLIBL HealthCare LtdRs 42.52P/E 19.1
- LIVENLiven Pharma LimitedRs 31.14
- MACTERMacter International LtdRs 259.64P/E 15.3
- OTSUOtsuka Pakistan LtdRs 366.30P/E 14.4
AGP: common questions
What is AGP's share price?
AGP Ltd (AGP) last closed at Rs 150.06 on the Pakistan Stock Exchange.
Does AGP pay a dividend?
Yes. AGP Ltd paid Rs 8.00 per share for the year to Dec 2025, and the stock's dividend yield is 4.7%.
What were AGP's latest results?
In the Apr–Jun 2026 quarter, AGP's sales fell 16% to Rs 4.7bn, from Rs 5.6bn, and profit after tax fell 8% to Rs 586.5mn, from Rs 636.0mn (compared with Apr–Jun 2025).
What is AGP's P/E ratio?
At Rs 150.06, AGP trades at 12.7 times its earnings.
Figures are taken from the company's published financial statements and PSX prices. This page is information, not investment advice.

